To this purpose, the study was conducted in two colon cancer cell lines, HCT116 and HT29, that differ in HDAC6 expression levels (Zhang et al., 2019) and may also display different lipid metabolism profiles. Here, HDAC6 is linked to malignant colon neoplasm.